Radical innovation in nanomaterials

Wednesday found me, yet again, in London, this time for a one-day meeting organised by the Royal Academy of Engineering called Radical Innovation in Nanomaterials (PDF link). The speakers were a mix of industrialists and innovation theorists, if I can put it that way, with me thrown in for light entertainment. I must say I find the idea of finding or creating a theory of radical innovation which would allow one to manage it predictably a bit hard to accept. But that’s presumably why I’m a humble academic rather than a high-flying business leader (or perhaps more pertinently, the multi-millionaire author of airport business books).

The talks from the industrialists were perhaps more interesting, not least because the underlying message coming out from all of them was so similar. On the face of it, the companies represented couldn’t have been more different. There were two global giants, the US based chemical company du Pont, and the Europe based pharmaceutical major, GlaxoSmithKline, and one relative minnow – the recently floated UK nanomaterials company Oxonica (whose CEO’s proud boast was that they are the only European pure nanotech company with products generating significant revenue). But the changing environment they were talking about was the same, and one that very much resonates with my comments earlier this week. It’s an atomised world in which innovation and intellectual property is generated by many different organisations – in universities and research institutions, in small start-up companies, but less and less in big corporate R&D labs. Core functions like production are increasingly outsourced, and companies like Oxonica flourish best as brokers, identifying useful intellectual property whereever they can, working with contract manufacturers to realise physical products, and then finding other partners – typically large consumer oriented companies – to develop markets for them.

It’s a model that fits well with prevailing neo-liberal orthodoxies about taking the globalised division of labour to the extreme. Of course it’s a model that must take for granted the absolute integrity and fungibility of intellectual property. I can’t help feeling that this leads to some major potential fragilities, given the difficulties that international patent law is currently going through. The other question that it seems to leave unanswered is this: if production is outsourced and essentially commoditised, who is going to drive the radical innovations, not in the products themselves, but in ways of making things? The orthodox answer, of course, is that competition by itself will do the job. Maybe.

Who’s in charge?

I spent Saturday afternoon in the Natural History Museum in London, not looking at the dinosaurs, but taking part in an event organised by the good people at Demos (not forgetting their colleagues at Lancaster) – nanoscientists-meet-nanopublics.

The format was a very gently moderated group discussion between nanoscientists of various ages (I think, alas, I was the oldest) and a group of members of the public who have been involved in a series of focus group discussions about nanotechnology. I’d summarise the demographic of my group as being “North London soccer mums” (with deep apologies to any of you who might read this!) – and I think it’s fair to say that the overall feeling towards nanotechnology was pretty negative. This was based on two things – an unease about untested nanoparticles in cosmetics, and a deeper unhappiness about the whole idea of human enhancement, particularly in a military context. I think we had a fairly productive discussion about both aspects.

One of the interesting things that came out in the discussion was this worry about “who is in charge”. I think it’s a natural human assumption to think that there is someone or some organisation that has the power to initiate change or to prevent it, if it is judged undesirable. But that’s not how science works in a liberal, globalised, market-driven system. I think this realisation that there really isn’t anyone in charge – not just in nanotechnology or any other part of science, but in all sorts of aspects of modern life – is what so many people find so frightening about the world we live in. But is there any alternative?

Framing nanotech: products, process, or program?

If you are a regulator or policy maker considering the possible impacts of nanotechnology, should you consider it solely in terms of the products it produces, should you think of it as a distinct process for making things, or should you ask about the more general socio-economic program of which it is part? This question is suggested by Sheila Jasanoff’s excellent new book, Designs on Nature. This book, recommended on Soft Machines the other day by James Wilsdon (see also James’s review of the book for the Financial Times), is a highly perceptive comparative study of the different ways in which the politics of biotechnology and genetic modification played out in the USA, the UK and Germany. Jasanoff finds one origin of the differences between the experience in the three countries in the different ways in which the technology was framed. In the USA, the emphasis was on asking whether the products of biotechnology were safe. In the UK, the issue was framed more broadly; the question was whether the process of genetic modification was in itself a cause for concern. In Germany, meanwhile, discussion of biotechnology could never escape the shadow of the complicity of German biomedical science with the National Socialist program, and the horrors that emerged from a state dedicated to the proposition than all men are not created equal. In this context, it was tempting to see biotechnology as part of a program in which science and a controlling, ordering state came together to subjugate both citizens and nature.

Since policy-makers, academics and activists are all looking at the unfolding debate around nanotechnology through the lens of the earlier GM debates, it’s worth asking how far this analysis can be applied to nanotechnology. The product-centred view is clearly in the ascendency in the USA, where the debate is centred almost exclusively over the issue of the possible toxicity of nanoparticles. But the process-centred view is not really managing to establish itself anywhere. The problem is, of course, that nanotechnology does not present a distinct process in the way that genetic modification does. This is despite the early rhetoric of the National Nanotechnology Initiative – the slogan “building the world atom-by-atom” does suggest that nanotechnology offers a fundamentally different way of doing things, but the reality, of course, is that today’s nanotechnology products are made by engineering processes which are only incremental developments of ones that have gone before. It remains to be seen whether a radically different nanotechnology will emerge which will make this framing more relevant.

Should we, then, worry about nanotechnology as part of a broader, socio-economic program? This is clearly the central position of anti-nanotechnology campaigning groups like the ETC group. They may find the nano-toxicity issue to be a convenient stick to beat governments and nano-industry with, but their main argument is not with the technology in itself, but with the broader issues of globalization and liberal economics. Of course, many of those most strongly in favour of nanotechnology have their own program, too – the idea of transhumanism, with its high profile adherents such as Ray Kurzweil. It’s possible that opposition to nanotechnology will increasingly come to be framed in terms of opposition to the transhumanist program, along the lines of Bill McKibben’s book Enough.

The Stalinists of public engagement…

The recent pamphlet from Demos on the need for public engagement about nanotechnology and other new technologies has received forthright criticism from the editor of Research Fortnight, William Bown. The original editorial raised the spectre of Lysenko, and accused advocates of public engagement of being “worse than Stalinists”. One of the authors of the Demos paper, James Wilsdon, has energetically responded. The resulting exchange of letters will be published in Research Fortnight, but those readers who unaccountably have forgotten to renew their subscription to that organ can read them on the Demos blog.

I’m not going to attempt to summarise Bown’s argument here (mainly because I find it rather difficult to follow). But I will single out one statement he makes to take issue with. Arguing that public engagement simply provides a mechanism to help governments avoid making difficult decisions, he says “The question for these two [Tony Blair and Gordon Brown], and their companions in Parliament, is not whether they think science is shiny and exciting; it is whether they back the deployment of nanotechnology.” This seems to me to combine naiveity about politics with a real misunderstanding of the nature of the science. All the debates about nanotechnology should have made one thing absolutely clear: nanotechnology is not a single thing (like nuclear power, say) that we can choose to use or to turn away from. It’s a whole variety of different technologies and potential technologies, with an equally wide range of potential applications. Choices need to be made – are being made right now, in fact – about which research avenues should be pursued, and which should be left to others, and one of the key roles of public engagement is to inform those choices.

More on Nanojury UK

Here are a few more links about Nanojury UK, the citizens’ jury on nanotechnology which has just reported its verdict.

The press release about the results, from Greenpeace.
An article about it, from the German newspaper die Tageszeitung (in German). Thanks to author Niels Boeing for letting me know about this.
Detailed commentary on the results and the launch day from David Berube (research director of NanoScience and Technology Studies at the University of South Carolina).

Finally, here’s a complete list of my posts on the process as it unfolded:
The launch
Week 1
Week 3
Finalising the conclusions
The verdict.

Nanojury UK – the final verdict

Nanojury UK – the citizens’ jury on Nanotechnology that has been deliberating over the summer – delivered its verdict on Wednesday at an event in London. In full, there were twenty recommendations which attracted various degrees of support. But at the launch, four jurors attended in person, and they singled out four recommendations which they felt the whole jury felt most strongly about. After presenting these four key recommendations, they took questions from a large audience, and then the sponsors of the process gave their reactions.

The four recommendations were:
1. Health – nano-enabled medicines had big potential for reducing the time people spent in hospital. These should be developed via improved funding mechanisms and should be available without discrimination on the National Health Service.
2. The Government should support those nanotechnologies that bring jobs to the UK by investment in education, training and research.
3. Scientists should learn to communicate better – some of the jury felt sometimes patronised, they didn’t like all the long words scientists used, and scientists didn’t always agree with each other.
4. Products containing manufactured nanoparticles should be labelled in plain English.

The questions threw up some interesting insights. The most direct and straightforward came from the Guardian reporter – after this process, what was their general impression of nanotechnology. All four were in agreement; if safety could be assured, they were very positive. Another journalist asked them what they felt were the most exciting applications, and again they agreed on medicine and renewable energy. A Greenpeace person asked them a rather leading question about whether they would agree with the proposition that he claimed many scientists held, that if the public only understood the science they would support it. They answered this by saying that as they learned about the science, they got excited about it and talked about it to their friends. One juror told a story about how his daughter was at school and the class was asked about nanotechnology. She said “oh, yes, I know loads about nanotechnology”, to which the teacher replied along the lines of “how can you know about that, your dad’s just a taxi driver”, to which she was able to say that her father was taking part in this citizens jury and was telling her all about it.

One thing was absolutely clear – the jurors were tremendously positive about the process itself. They even managed to say some positive things about the scientists involved, despite conclusion 3. One juror rather accurately identified the problem with the upstream nature of the process – commenting that “some of this stuff is so far ahead that even the scientists aren’t sure where it is going”. This positive view chimed well with the independent evaluation made by Nick Pidgeon, a social scientist from UEA who assessed the ill-fated GM nation project. His view was also very positive, and he noted as good features the very representative jury, the very strong multi-stakeholder oversight panel, and the direct link into government. He noted as a challenge for upstream approach precisely the problem that the juror had pointed out.

From the sponsors, Mark Welland, from the Cambridge Nanotechnology IRC, talked a lot about the importance of the integrity of the process, and pronounced himself very satisfied with this. Doug Parr, from Greenpeace, sounded a slight air of disappointment. He didn’t think the recommendations reflected the richness of the discussions, he noted the importance of discussing, beyond pure technology, the wider issues of economics and the wider disconnects between science, government, industry and the public. He noted that there had been no mention of the idea of a moratorium on the new technology. I should note here, of course, that Jim Thomas, of the ETC group, which has been calling for a moratorium, was one of the witnesses and presented the case for one to the jury.

For the Government, the reaction was given by Adrian Butt, Chair of the Nanotechnology Issues Dialogue Group, the multi-department body set up to coordinate nanotechnology policy across government. He gave an explicit commitment to table the recommendations in the policy meetings of the NIDG and report back the outcome of discussions. He seemed really rather pleased with the outcome, which he took as being not far from endorsing the approach the government was taking. Nonetheless, he did exercise a certain amount of “expectations management” about how seriously the government would take this. In his words, “the results of this kind of exercise will not by themselves directly determine policy, but will provide social intelligence on the wider environment in which policy is made”

For nanobusiness, Barry Park, COO of Oxonica, expressed broad comfort with the balanced tone of the recommendations.

What of my personal recollections and feelings? I found it one of the most stressful things I’ve done in my career. I have massive admiration for Becky Willis, who chaired the oversight panel and kept the whole thing together in the face of what seemed at times overwhelming centrifugal forces (I composed one unsent resignation letter, and I suspect I wasn’t the only one who came close to walking out on the whole thing). The facilitators have immense power in this kind of exercise, and I ended up with immense respect for the professional effectiveness of Tom Wakeford and his team. But Tom has his own strong political views, which as he himself conceded in his own self-critique, he doesn’t always rigorously exclude from the process, and these aren’t calculated to make life easy for the scientists. It would be impossible for me not to take the criticisms of scientists communication skills personally, but I honestly don’t think the scientific witnesses should have done anything differently. I think the jurors got a very honest, unspun and unvarnished impression of the science, and in return I found the interactions with the jurors very rewarding.

At the end of it all, one thing that is disappointing was the very low level of press coverage – this perfunctory piece in the Guardian was the only thing in the nationals. There are some mitigating circumstances for the lack of press interest – the fact that the Guardian was the media sponsor limited the appeal for other papers, while the Guardian itself basically lost interest as a result of the decision to drop its weekly science section when the paper relaunched as a near-tabloid. But I can’t help feeling that there would have been a lot more coverage if the result had been different. There were approving words in an editorial in this weeks Nature (subscription required). Its conclusion is a good place to finish: “The results of the citizens’ jury suggest that nanotechnology is not perceived as a serious threat to the values of anyone but die-hard anti-technologists”.

Nanotechnology Engagement Group

I was in London on Monday for the first meeting of the Nanotechnology Engagement Group (NEG), a body funded by the UK government to coordinate activities around public engagement and the discussion of social and ethical issues in the context of nanotechnology. The establishment of the body was announced in a rather low-key way in the summer, when the government issued its draft strategy public engagement on nanotechnologies. The group is being run by the think-tank Involve, and I’m chairing it.

Here are a few first impressions, mostly of the potential pitfalls that it’s easy to imagine this enterprise falling into. The first is that it might cement the trend already identified by Demos, and contribute to a simultaneous professionalization and marginalization of the public engagement field. One can easily imagine NEG developing as a forum in which the professionals cheerfully discuss at length the methodological advantages of citizens’ juries against consensus conferences or focus groups, while failing to make any real impact either on the development of science policy or on the wider public discourse about technology as it’s carried out through the media.

The second is the tension that exists between the idea of public engagement and the idea of “engaging stakeholders”. A very popular way of doing some sort of wider consultation about something like technology is to assemble a bunch of “stakeholders” – regulators, industry groups, consultancy organisations, and advocacy groups. I have deep worries about the representativeness of such groups on all sides. There’s an unwillingness of the private sector to put its collective head above the parapet, on the one hand, and on the other there’s a tendency to assume that NGOs, sometimes representing very narrow constituencies, have a mandate to represent the concerns of a wider public. It’s tempting to view the results of such consultations as being much more representative than they are; when so many people are unwilling or unable to speak the voice of anyone who is willing and motivated to say anything at all ends up with far too much weight. This, to my mind, is one of the main strengths of processes like citizens’ juries – done well, you should get something that represents the views of the public much more accurately than an advocacy group.

Finally, there is the question of what the public, in these engagement exercises, are actually being asked to decide on. The drawback of this kind of upstream engagement is that it is not clear what the outcomes of the technology might be. Maybe we need to start doing some serious scenario construction to try and present a range of plausible futures to focus the discussion down a bit.

All these issues come into sharp focus with the launch of the findings of Nanojury UK (see here for previous reports on this), which took place today at the headquarters of the Guardian. I’ll be writing my impressions about the launch event tomorrow.

Uncertainties about public engagement

The thinktank Demos has released another report on science and public engagement. The Public Value of Science is, in some ways, a follow up to their earlier pamphlet See-through Science. But whereas the earlier report was rather confident in its diagnosis of the failings of previous attempts to engage the public in science, and in its prescription of a new type of “upstream engagement”, the new report seems much more uncertain in its tone.

On the face of it, this is odd, because the news seems good. There is no evidence of any growing crisis in public confidence in science; on the contrary, the report quotes a recent opinion poll from the UK which found that “86 per cent of people think science ‘makes a good contribution to society’– up 5 per cent on two years ago.”. And the idea of “upstream engagement” is riding high in fashionability, both in government and among the scientific great and good. Nonetheless, there seems to be a nagging worry, a sense that this conversion to real public engagement is only skin deep. It’s true that there’s been some open opposition (for example from Lord Taverne’s organisation, Sense about Science) but this seems to worry Demos less than the feeling that all the attention paid to public engagement still amounts to little more than lip-service, leading to “a well-meaning, professionalised and busy field,propelled along by its own conferences and reports, but never quite impinging on fundamental practices,assumptions and cultures. “

I think they are quite right. The danger they have identified is that all this activity about public engagement still isn’t actually pulling the levers they need to operate to achieve their ambition, which is to steer the direction of the research enterprise itself. The next phase is to work on what they call the “software” of scientific engagement – “the codes,values and norms that govern scientific practice,but which are far harder to access and change.” This is a much more difficult matter than simply setting up a few focus groups and citizens’ juries. In essence, their aim here is to use the input from this kind of deliberative process to redefine the way the scientific community defines “good science”.

This kind of cultural shift isn’t entirely unprecedented. In fact, I’ve argued myself that the rise of nanoscience itself constitutes just such a shift; in this case the definition of good science swung away from testing theories and characterising materials, and towards making widgets or gizmos. But the process of change is difficult, unpredictable and hard to control. It’s not about the Minister for Science issuing a rational order to his obedient research councils; the process is probably closer to the way fashions spread among sub-teenagers. The editors of Nature and Science, like the editors of Smash Hits, might think they have some influence, but they’re at the mercy of the social dynamics of the playground. One obvious difficulty is that the values of the scientific enterprise are now highly globalized. All over the world scientists aspire to publish the same kinds of paper in the same journals, and to be invited to the same conferences. Another difficulty is the sheer self-confidence of the scientific community. Lord Broers’ Reith lectures captured the spirit exactly – paraphrasing Marx, scientists may concede that philosophers and social scientists have done something to understand the world, but scientists and technologists have a deep conviction that it is they who have changed it.

Moving to some more parochial issues, the report identifies some specific barriers that UK scientific politics puts in the way of their vision. The Research Assessment Exercise, which determines the level of baseline research funding in UK universities over a five year period, operates on a strictly disciplinary basis, using peer review of papers describing original research. There’s been some lip-service paid to the notion that there may be valid outputs that aren’t papers in Physical Review Letters, but I’m not sure many people are going to be willing to gamble on this, and I can’t disagree with Demos’s conclusion that ‘”it reinforces the model ofthe highly specialised researcher,locked in a cycle of publish-or-perish”. The research councils clearly see some of the problems and are starting some useful initiatives, but they’re hampered by the difficulty that the different councils have in working cooperatively. The big picture, though, is that there are precious few career incentives for scientists to divert their efforts in this way, and quite a few significant disincentives.

The big weakness in the Demos analysis, in my view, is its failure to address the issue of the power of the market. The authors are very equivocal about the growing emphasis on the commercialisation of university generated research. Agreeing that in principle this is a good thing, they nonetheless report ” growing disquiet among university scientists that the drive for ever closer ties with business is distorting research priorities”, and worry about the effects of this on the openness and integrity of the research process. All these are valid concerns, but what’s missing is a recognition that the market is now the predominant mechanism by which technology impacts on society. Demos says “We believe everyone should be able to make personal choices in their daily lives that contribute to the common good. “ The truth is, the way society is set up now what people buy is one of the major ways in which these choices are made. And the messages that people send through the market by these personal choices might well differ from the messages they would send if you asked them directly. If you ask a bunch of young people where they would like to see money spent to develop nanotechnology, they might well answer that they’d like to see it being spent on improving the environment and on ending world poverty, but then if they go and spend their money on iPods and personal care products their votes are effectively cast for quite different priorities.

This isn’t to say that the market is a very efficient way of setting research priorities – far from it. At the moment we have marketing and product development people making more or less informed guesses (which often turn out to be spectacularly inaccurate) about what people are going to want to buy. On the other hand, researchers are obliged to try and predict some kind of application for the outcome of their research when they apply for funding, and to do this they end up trying to guess, not so much what the potential markets might be, but what they think will best match the preconceptions of referees and research councils. Somehow the idea that in ten years everyone will want flexible television sets, or personal gene testing kits, or neutriceutical laden yoghourts, enters and spreads through the collective mind of the research community like a Pokemon craze. This isn’t to say that these ideas are necessarily wrong; it’s just that the process by which they gain currency is not particularly well controlled or evidence based. It’s this sort of process that sociologists of science ought to understand, but I’m not convinced they do.

Nanotechnology debate at Nottingham

I don’t know about anybody else, but I enjoyed yesterday’s nanotechnology debate at Nottingham. The whole thing was filmed, and as soon as it’s been edited and tidied up we’ll get the video put up on the web. Given that everyone will soon have the opportunity to judge for themselves how the thing went, I’ll confine myself here to some general observations. There was a big crowd, mostly graduate students attending the surface science summer school, supplemented by a good fraction of the local nanoscientists. The nature of the audience meant that the debate rapidly got quite technical; I don’t think anyone could say that the molecular manufacturing point of view didn’t get a serious hearing. I must say that I was a little apprehensive, given the rancour that has entered previous debates, but I felt the tone was robust but mutually respectful.

My prize for gnomic aphorism of the evening goes to my fellow-panellist Saul Tendler (bionanotechnologist and pharmacy professor). “If a cat had wheels, who would change its tyres?”

Nanotechnology and human enhancement

A session at the British Association’s annual meeting in September, which this year is being held in Dublin, is devoted to a debate on the topic “Should we enhance ourselves: does nanotechnology have limits”. The debate, which is between 7 pm and 9 pm on Tuesday 6 September, has been put together by Donald Bruce, the Director of the Church of Scotland’s Science, Religion and Technology Project. The speakers are myself, Donald, and Paul Galvin, teamleader for Nanobiotechnology at the Tyndall National Institute in Cork.